Company intelligence / Profile preview

Leios Therapeutics

Basel, Basel-Stadt, Switzerlandleiostherapeutics.com ↗
Ownership
Private
Development stage
Other
01

Overview

Leios Therapeutics is an early-stage biotechnology company incubated by Versant Ventures, focused on developing novel small molecule therapeutics for dermatological conditions and inflammatory skin diseases.

Therapeutic areas
Dermatology
Modalities
Small molecule
Industry
Biotech
02

Drug pipeline

1 asset

10XB101

4
03

Partnerships

Ridgeline Discovery

Beyond the preview

Go deeper on Leios Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leios Therapeutics.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call